Fig. 1: Smoothing plots of platelet activation parameters and first stroke risk by MTHFR C677T genotypes among treatment groups. | Signal Transduction and Targeted Therapy

Fig. 1: Smoothing plots of platelet activation parameters and first stroke risk by MTHFR C677T genotypes among treatment groups.

From: Effect of plateletcrit and methylenetetrahydrofolate reductase (MTHFR) C677T genotypes on folic acid efficacy in stroke prevention

Fig. 1

Smoothing plots of platelet activation parameters and first stroke risk by MTHFR C677T genotypes among the enalapril group (a, c, e, g) and the enalapril-folic acid group (b, d, f, h). a, c, e, g Smoothing plots of plateletcrit, platelet count, mean platelet volume, platelet distribution width and first stroke risk stratified by the MTHFR C677T genotypes (CC/CT vs. TT) among the enalapril group. b, d, f, h Smoothing plots of plateletcrit, platelet count, mean platelet volume, platelet distribution width and first stroke risk stratified by the MTHFR C677T genotypes (CC/CT vs. TT) among the enalapril-folic acid group

Back to article page